{"ok":true,"trend":{"id":744171,"platform":"news","region":"global","key":"j&j's innovative medicine segment in q3: key growth drivers to watch","title":"J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch","url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNUWE1bVczNW1COHF2SnJRNnZwSE1YSHFFLXJxZU9VcEVFQjk5TEdhVk4zcWgzZm1ZRmNteVNvdG1vTGdUWkVsSlBYa1JRcHp1aHM4OTlmTE1EVjJtZzlqZWpRODFBS0JPTFlXaENieXZ0Mkl5WkZFcGtubmVtN0N3a2pBdThOczNHcTFnTmFLb041b05FQV80NA?oc=5","first_seen":"2026-10-02T14:34:35.057330Z","last_seen":"2026-10-03T08:23:30.285537Z","last_rank":32,"peak_rank":8,"last_volume":null,"peak_volume":0,"seen_count":11,"score":0.55921875,"category_hint":"medicine","section":"health","category":"medicine","summary":"Johnson & Johnson's Innovative Medicine segment is in focus ahead of its third-quarter results, with analysts highlighting the key growth drivers investors should watch, including performance of its pharmaceutical portfolio and pipeline developments. Financial outlets are framing the quarter as a test of the segment's momentum within the company's broader business.","why":"Investors and analysts are anticipating J&J's Q3 earnings and assessing growth prospects for its pharmaceutical business.","tone":"neutral","entities":["Johnson & Johnson","Innovative Medicine"],"summarized_at":"2026-10-03T10:52:38.340324Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Yahoo Finance","published":"Fri, 02 Oct 2026 12:30:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"J&J Q3 Focus: Innovative Medicine Growth Drivers","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-10-02T14:34:35.057330Z","rank":8,"volume":null},{"captured_at":"2026-10-02T15:56:33.379918Z","rank":25,"volume":null},{"captured_at":"2026-10-02T21:25:32.655435Z","rank":18,"volume":null},{"captured_at":"2026-10-02T22:47:33.001784Z","rank":19,"volume":null},{"captured_at":"2026-10-03T00:10:32.411441Z","rank":23,"volume":null},{"captured_at":"2026-10-03T01:33:11.343235Z","rank":27,"volume":null},{"captured_at":"2026-10-03T02:55:13.299706Z","rank":28,"volume":null},{"captured_at":"2026-10-03T04:17:32.058942Z","rank":29,"volume":null},{"captured_at":"2026-10-03T05:39:31.186574Z","rank":30,"volume":null},{"captured_at":"2026-10-03T07:01:36.453680Z","rank":34,"volume":null},{"captured_at":"2026-10-03T08:23:30.285537Z","rank":32,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNUWE1bVczNW1COHF2SnJRNnZwSE1YSHFFLXJxZU9VcEVFQjk5TEdhVk4zcWgzZm1ZRmNteVNvdG1vTGdUWkVsSlBYa1JRcHp1aHM4OTlmTE1EVjJtZzlqZWpRODFBS0JPTFlXaENieXZ0Mkl5WkZFcGtubmVtN0N3a2pBdThOczNHcTFnTmFLb041b05FQV80NA?oc=5","author":"Yahoo Finance","title":"J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch","snippet":null,"posted_at":"2026-10-02T12:30:00Z","likes":null},{"platform":"news","url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNT3FyUlJuZ3dwMjJFQmRVWGJPLWRwNEUyTkZsZnMtMFk0TG9UaTZUcWZPQzVEcE5iV2RZRWFBV29XSUdvUDBralRmaVdXRnEtenRsVHV4M2FDUGJHMzhpcEh0bWthd3ZaemZUNHFUd0JjMnFodTNlY0hEb1JVd3hOcmhOWnUxSWdEc2Jac1JtbVpGUmM2WFZuRDJHWDA0WmMtMmRaUk9aeERQS3ZMZjJEaUhLOGhyNWFWVmFFcjFWWmtTZHRtNWE0dXFFWEJ4cWxkN1FWaHVlbDZiQUF6bFl4bGl6bWI?oc=5","author":"The Globe and Mail","title":"J&J's Innovative Medicine Segment in Q3: Key Growth Drivers to Watch","snippet":null,"posted_at":"2026-10-02T14:35:19Z","likes":null}],"elsewhere":[],"window":"7d"}}